Evidence map›Paper›PMID 35679363›Full record

ReviewCirculation research2022

Animal Models of Dysregulated Cardiac Metabolism.

Heiko Bugger, Nikole J Byrne, E Dale Abel

Open access · bronzeAbstract readReview
In one paragraph

Review in Circulation research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Metabolic syndrome and a broken heart: trust your gut or risk your heart.American journal of physiology. Heart and circulatory physiology · 2026
    Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. The role of sphingolipids in heart failure.European heart journal open · 2025
    Review
  9. Article
  10. Article
  11. Protective Effect of Carbon Dots Derived fromNanomaterials (Basel, Switzerland) · 2025
    Article
  12. Review
  13. Effects ofPharmaceutics · 2024
    Article
  14. Article
  15. Article
  16. Review
  17. NAD in pathological cardiac remodeling: Metabolic regulation and beyond.Biochimica et biophysica acta. Molecular basis of disease · 2024
    Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Heiko BuggerUniversity Heart Center Graz, Department of Cardiology, Medical University of Graz, Graz, Austria, Austria (H.B., N.J.B.).
Nikole J ByrneUniversity Heart Center Graz, Department of Cardiology, Medical University of Graz, Graz, Austria, Austria (H.B., N.J.B.).
E Dale AbelDepartment of Medicine, David Geffen School of Medicine, University of California, Los Angeles (E.D.A.).
Medical University of Graz · ATUniversity of California, Los Angeles · US

Funding

ANIMAL MODELS OF DIABETIC CARDIOVASCULAR COMPLICATIONSU01HL070525 · NHLBI · UNIVERSITY OF UTAH · PI MCCLAIN, DONALD A · 2001 to 2005
$3.7M
Insulin Inhibition of beta-AR Signaling in the MyocardiumR01HL127764 · NHLBI · UNIVERSITY OF IOWA · PI ABEL, E DALE, XIANG, YANG K · 2015 to 2018
$2.4M
Insulin resistance and cardiac dysfunction in obesityR01HL073167 · NHLBI · UNIVERSITY OF UTAH · PI ABEL, EVAN DALE · 2003 to 2007
$2.0M
Modeling Diabetic Cardiomyopathy and Microangiopathy U01HL087947 · NHLBI · UNIVERSITY OF UTAH · PI ABEL, E DALE · 2006 to 2010
$1.8M
Cardiac Dysfunction in the Met Syndrome: Cross-talk between IR and bAR SignalingR01HL112413 · NHLBI · UNIVERSITY OF IOWA · PI ABEL, E DALE, XIANG, YANG K · 2015 to 2018
$1.6M
Insulin Resistance and Myocardial AutophagyR01HL108379 · NHLBI · UNIVERSITY OF UTAH · PI ABEL, E DALE · 2011 to 2014
$1.5M
Insulin Signaling and the Heart in DiabetesR01DK092065 · NIDDK · UNIVERSITY OF UTAH · PI ABEL, E DALE · 2010 to 2011
$649k
NHLBI NIH HHS R01 HL073167NHLBI NIH HHS R01 HL108379NHLBI NIH HHS R01 HL112413NHLBI NIH HHS R01 HL127764NHLBI NIH HHS U01 HL070525NHLBI NIH HHS U01 HL087947NIDDK NIH HHS R01 DK092065
6 · The paper itself

Abstract

As a muscular pump that contracts incessantly throughout life, the heart must constantly generate cellular energy to support contractile function and fuel ionic pumps to maintain electrical homeostasis. Thus, mitochondrial metabolism of multiple metabolic substrates such as fatty acids, glucose, ketones, and lactate is essential to ensuring an uninterrupted supply of ATP. Multiple metabolic pathways converge to maintain myocardial energy homeostasis. The regulation of these cardiac metabolic pathways has been intensely studied for many decades. Rapid adaptation of these pathways is essential for mediating the myocardial adaptation to stress, and dysregulation of these pathways contributes to myocardial pathophysiology as occurs in heart failure and in metabolic disorders such as diabetes. The regulation of these pathways reflects the complex interactions of cell-specific regulatory pathways, neurohumoral signals, and changes in substrate availability in the circulation. Significant advances have been made in the ability to study metabolic regulation in the heart, and animal models have played a central role in contributing to this knowledge. This review will summarize metabolic pathways in the heart and describe their contribution to maintaining myocardial contractile function in health and disease. The review will summarize lessons learned from animal models with altered systemic metabolism and those in which specific metabolic regulatory pathways have been genetically altered within the heart. The relationship between intrinsic and extrinsic regulators of cardiac metabolism and the pathophysiology of heart failure and how these have been informed by animal models will be discussed.

Indexed as

Heart FailureMyocardiumAnimalsEnergy MetabolismFatty AcidsHeartMitochondria, HeartModels, AnimalFatty Acidsdiabetesglucoseheart failuremitochondriamodels, animal

Identifiers

PMID35679363
PMCPMC9261483
OpenAlexW4281968310

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.